Meditation and De-Addiction: A Neurobiological Perspective

Addiction involves compulsive substance use and impaired self-regulation, driven by neurobiological changes in the prefrontal cortex, amygdala, hippocampus, and mesolimbic reward system that disrupt reward processing, cognitive control, and stress regulation, leading to heightened cravings and relapse vulnerability. Preliminary evidence suggests meditation may influence these systems by modulating prefrontal-limbic connectivity, normalizing stress responses via the HPA axis, and enhancing neuroplasticity. However, findings are mixed and limited by methodological shortcomings, precluding definitive conclusions. Rigorous controlled studies with standardized protocols, larger samples, and longer follow-ups are needed to establish clinical efficacy.

Study at a glance

Abstract

Background: Addiction is a multifaceted disorder involving compulsive substance use, impaired self-regulation, and continued use despite adverse consequences. Neurobiological alterations in key brain regions, including the Prefrontal Cortex (PFC), amygdala, hippocampus, and mesolimbic reward system, underlie addiction pathophysiology. These changes disrupt reward processing, cognitive control, and stress regulation, contributing to heightened cravings and relapse vulnerability. Emerging evidence suggests meditation may modulate these neurobiological pathways. Objective: This review explores the neurobiological mechanisms underlying addiction and evaluates potential therapeutic effects of meditation on these pathways. Methods: A narrative review of current literature was conducted, synthesizing evidence from neurobiological studies, clinical trials, meta-analyses, and systematic reviews examining meditation interventions in addiction populations. Results: Current evidence suggests addiction involves dysregulation of the mesolimbic reward system, with altered dopamine signalling, impaired PFC function, and amygdala hyperactivity. Preliminary research indicates meditation may influence these systems through multiple mechanisms, including modulation of prefrontal-limbic connectivity, stress response normalization via the Hypothalamic-Pituitary-Adrenal (HPA) axis, and enhanced neuroplasticity. However, findings remain mixed, with significant methodological limitations across studies. Conclusion: While preliminary evidence suggests meditation may engage neurobiological pathways implicated in addiction, current research limitations preclude definitive conclusions. Further rigorous, controlled studies with standardized meditation protocols, larger sample sizes, and longer follow-up periods are essential to establish clinical efficacy and elucidate specific mechanisms of action.